In the Italian study, Quintaville et al. reported NGAL PPV and NPV of 20% and 93%, respectively [41], thus demonstrating the superiority of NGAL in excluding patients at risk for CIN and suboptimal accuracy for diagnosing CIN. The gene discussed is LCN2; the disease is cervical squamous intraepithelial neoplasia.